UG vs. SHOT, UNCY, BGXX, BCTX, ESLA, OCUP, LNSR, XLO, PXDT, and CARA
Should you be buying United-Guardian stock or one of its competitors? The main competitors of United-Guardian include Safety Shot (SHOT), Unicycive Therapeutics (UNCY), Bright Green (BGXX), BriaCell Therapeutics (BCTX), Estrella Immunopharma (ESLA), Ocuphire Pharma (OCUP), LENSAR (LNSR), Xilio Therapeutics (XLO), Pixie Dust Technologies (PXDT), and Cara Therapeutics (CARA). These companies are all part of the "medical" sector.
United-Guardian (NASDAQ:UG) and Safety Shot (NASDAQ:SHOT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, community ranking, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.
United-Guardian has a net margin of 23.71% compared to Safety Shot's net margin of -367.77%. United-Guardian's return on equity of 24.26% beat Safety Shot's return on equity.
23.2% of United-Guardian shares are held by institutional investors. Comparatively, 12.6% of Safety Shot shares are held by institutional investors. 29.0% of United-Guardian shares are held by company insiders. Comparatively, 23.1% of Safety Shot shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
United-Guardian has higher revenue and earnings than Safety Shot. Safety Shot is trading at a lower price-to-earnings ratio than United-Guardian, indicating that it is currently the more affordable of the two stocks.
In the previous week, Safety Shot had 12 more articles in the media than United-Guardian. MarketBeat recorded 15 mentions for Safety Shot and 3 mentions for United-Guardian. United-Guardian's average media sentiment score of 0.10 beat Safety Shot's score of -0.02 indicating that United-Guardian is being referred to more favorably in the media.
United-Guardian received 177 more outperform votes than Safety Shot when rated by MarketBeat users.
United-Guardian has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, Safety Shot has a beta of 1.74, meaning that its stock price is 74% more volatile than the S&P 500.
Summary
United-Guardian beats Safety Shot on 11 of the 14 factors compared between the two stocks.
Get United-Guardian News Delivered to You Automatically
Sign up to receive the latest news and ratings for UG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding UG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
United-Guardian Competitors List
Related Companies and Tools
